Frontiers | Glioblastoma Organoids: Pre-Clinical Applications and Challenges in the Context of Immunotherapy
Biomedicines | Free Full-Text | Metal-Based Nanostructured Therapeutic Strategies for Glioblastoma Treatment—An Update | HTML
Development of a novel preclinical glioblastoma mouse model and therapeutic impact of IRE1 inhibition | bioRxiv
A humanized orthotopic tumor microenvironment alters the bone metastatic tropism of prostate cancer cells | Communications Biology
Injectable nanomedicine hydrogel for local chemotherapy of glioblastoma after surgical resection - ScienceDirect
Cancers | Free Full-Text | In Vitro Glioblastoma Models: A Journey into the Third Dimension | HTML
Novel model of orthotopic U-87 MG glioblastoma resection in athymic nude mice - ScienceDirect
Post-resection treatment of glioblastoma with an injectable nanomedicine-loaded photopolymerizable hydrogel induces long-term survival - ScienceDirect
STING activation promotes robust immune response and NK cell–mediated tumor regression in glioblastoma models | PNAS
Hyaluronic acid-based hydrogels loaded with chemoattractant and anticancer drug – new formulation for attracting and tackling glioma cells - Soft Matter (RSC Publishing) DOI:10.1039/D1SM01003D
Intracavity-injected hydrogel system significantly suppressed tumour... | Download Scientific Diagram
Engineered biomimetic nanoparticles achieve targeted delivery and efficient metabolism-based synergistic therapy against glioblastoma | Nature Communications
Frontiers | Evolution of Experimental Models in the Study of Glioblastoma: Toward Finding Efficient Treatments
A patient-designed tissue-engineered model of the infiltrative glioblastoma microenvironment | npj Precision Oncology
Apatinib inhibits glioma cell malignancy in patient-derived orthotopic xenograft mouse model by targeting thrombospondin 1/myosin heavy chain 9 axis | Cell Death & Disease
Inducing CAR-macrophages in the brain for local treatment
Nanocarrier-based drug combination therapy for glioblastoma
Frontiers | Local Delivery and Glioblastoma: Why Not Combining Sustained Release and Targeting?
A comparative study of brain tumor cells from different age and anatomical locations using 3D biomimetic hydrogels - ScienceDirect
Development of a Prodrug of Camptothecin for Enhanced Treatment of Glioblastoma Multiforme | Molecular Pharmaceutics
